The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
COVID-19: Disease, management, treatment, and social impact
Open accessAbstract
COVID-19 was originated from Wuhan city of Hubei Province in China in December 2019. Since then it has spread in more than 210 countries and territories. It is a viral disease due to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. The patients show flu-like symptoms with a dry cough, sore throat, high fever, and breathing problems. The disease due to SARS-CoV-2 was named as COVID-19. About 2.2 million people have been infected with more than 0.15 million deaths globally. The United States of America is the most affected country with the highest patients of about 0.7 million. Despite great efforts, there is no treatment of this disease. However, prevention and management are the best options. This article describes SARS-CoV-2, disease, prevention and management, treatment and social impact on society. It was analyzed that a combination of antiviral drugs with hydroxyl-chloroquine and azithromycin (with the consultation of a medical practitioner) may be the best option to treat the patients, depending on the patient's conditions and symptoms. However, Unani therapy may be useful along with allopathic treatment. It is urgently advised and requested that all the persons should follow the preventive measures, managements and quarantine strictly without any religious discrepancy otherwise the situation may be the worst. Also, there is an urgent requirement to educate our new generation for science and technology to fight against any such disaster in future; if any. There is no need to be panic and proper prevention and management are essential to combat this disease. This article may be useful to create awareness among the public, to prevent, manage and treat COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · cited 1×
“with some severe cases having pneumonia, serious respiratory syndrome, kidney failure and even death (Huang et al., 2020; Hui et al., 2020; Ren et al., 2020).”
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244 · cited 1×
“9% resemblance to a bat coronavirus, and, hence, is suspected to develop from bats (Lu et al., 2020; Wan et al., 2020; Zhu et al., 2020).”
BackgroundChen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z.-L. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,515
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341 · cited 3×
“It depends on the age, health and clinical conditions of the patients (Wan et al., 2020).”
BackgroundHui, D. S., I Azhar, E., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., Mchugh, T. D., Memish, Z. A., Drosten, C., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.009 · Cited by 3,809
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C. K., Zhou, J., Liu, W., Bi, Y., & Gao, G. F. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.03.003 · Cited by 2,948
F. T. Z. H. O. W. U. N. C. M. A. R. T., Jin, Y.-H., Cai, L., Cheng, Z.-S., Cheng, H., Deng, T., Fan, Y.-P., Fang, C., Huang, D., Huang, L.-Q., et al. (2020) · Military Medical Research · doi:10.1186/s40779-020-0233-6 · Cited by 2,254
Sheahan, T. P., Sims, A. C., Leist, S. R., Schäfer, A., Won, J., Brown, A. J., Montgomery, S. A., Hogg, A., Babusis, D., Clarke, M. O., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13940-6 · Cited by 1,738
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Li, G., & De Clercq, E. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00016-0 · Cited by 1,729
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
Chu, C. M. (2004) · Thorax · doi:10.1136/thorax.2003.012658 · Cited by 1,645
Agostini, M. L., Andres, E. L., Sims, A. C., Graham, R. L., Sheahan, T. P., Lu, X., Smith, E. C., Case, J. B., Feng, J. Y., Jordan, R., et al. (2018) · mBio · doi:10.1128/mbio.00221-18 · Cited by 1,416
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.
Ren, L.-L., Wang, Y.-M., Wu, Z.-Q., Xiang, Z.-C., Guo, L., Xu, T., Jiang, Y.-Z., Xiong, Y., Li, Y.-J., Li, X.-W., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000722 · Cited by 1,349
Drug treatment options for the 2019-new coronavirus (2019-nCoV)
Lu, H. (2020) · BioScience Trends · doi:10.5582/bst.2020.01020 · Cited by 1,133
Belouzard, S., Chu, V. C., & Whittaker, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809524106 · Cited by 1,073
Morse, J. S., Lalonde, T., Xu, S., & Liu, W. R. (2020) · ChemBioChem · doi:10.1002/cbic.202000047 · Cited by 776
Effects of Air Temperature and Relative Humidity on Coronavirus Survival on Surfaces
Casanova, L. M., Jeon, S., Rutala, W. A., Weber, D. J., & Sobsey, M. D. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.02291-09 · Cited by 735
Identification of natural compounds with antiviral activities against SARS-associated coronavirus
LI, S., CHEN, C., ZHANG, H., GUO, H., WANG, H., WANG, L., ZHANG, X., HUA, S., YU, J., & XIAO, P. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.02.007 · Cited by 602
The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb
Wang, L., Yang, R., Yuan, B., Liu, Y., & Liu, C. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.005 · Cited by 590
COVID-19 Disease due to SARS-CoV-2 (Novel Coronavirus)
Carlos, W. G., Dela Cruz, C. S., Cao, B., Pasnick, S., & Jamil, S. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2014p7 · Cited by 581
Garlic: a review of potential therapeutic effects.
Bayan, L., Koulivand, P. H., & Gorji, A. (2014) · Europe PMC (PubMed Central) · Cited by 559
Antiviral Natural Products and Herbal Medicines
Lin, L.-T., Hsu, W.-C., & Lin, C.-C. (2014) · Journal of Traditional and Complementary Medicine · doi:10.4103/2225-4110.124335 · Cited by 529
Antiviral effects of Glycyrrhiza species
Fiore, C., Eisenhut, M., Krausse, R., Ragazzi, E., Pellati, D., Armanini, D., & Bielenberg, J. (2008) · Phytotherapy Research · doi:10.1002/ptr.2295 · Cited by 458
Anti-infective Properties of the Golden Spice Curcumin
Praditya, D., Kirchhoff, L., Brüning, J., Rachmawati, H., Steinmann, J., & Steinmann, E. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00912 · Cited by 373
Chang, J. S., Wang, K. C., Yeh, C. F., Shieh, D. E., & Chiang, L. C. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.10.043 · Cited by 369
In Vitro Virucidal Effects of Allium sativum(Garlic) Extract and Compounds
Weber, N., Andersen, D., North, J., Murray, B., Lawson, L., & Hughes, B. (1992) · Planta Medica · doi:10.1055/s-2006-961504 · Cited by 327
Xu, Z., Shi, D., Han, J.-B., Ling, Y., Jiang, X., Lu, X., Li, C., Gong, L., Ge, G., Zhang, Y., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01429-0 · Cited by 301
Sexton, N. R., Smith, E. C., Blanc, H., Vignuzzi, M., Peersen, O. B., & Denison, M. R. (2016) · Journal of Virology · doi:10.1128/jvi.00080-16 · Cited by 209
Fatima, M. T., Zaidi, N. S., Amraiz, D., & Afzal, F. (2016) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1508.08024 · Cited by 160
A Tale of Two Viruses: The Distinct Spike Glycoproteins of Feline Coronaviruses
Jaimes, J. A., Millet, J. K., Stout, A. E., André, N. M., & Whittaker, G. R. (2020) · Viruses · doi:10.3390/v12010083 · Cited by 160
Momattin, H., Al-Ali, A. Y., & Al‐Tawfiq, J. A. (2019) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2019.06.012 · Cited by 138
Anti-influenza A virus effects of fructan from Welsh onion (Allium fistulosum L.)
Lee, J., Miyake, S., Umetsu, R., Hayashi, K., Chijimatsu, T., & Hayashi, T. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.04.016 · Cited by 100
Kim, H., Eo, E., Park, H., Kim, Y., Park, S., Shin, H., & Kim, K. H. (2010) · Antiviral Therapy · doi:10.3851/imp1615 · Cited by 71
Pharmacological Evaluation of Ocimum sanctum
Bano, N., Ahmed, A. A. E., Tanveer, M., Khan, G. M., & Ansari, M. (2017) · Journal of Bioequivalence & Bioavailability · doi:10.4172/jbb.1000330 · Cited by 70
Review of Antiviral Effects of Glycyrrhiza glabra L. and Its Active Component, Glycyrrhizin
Asl, M. N., & Hosseinzadeh, H. (2007) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 20
Cited by
Impacts of COVID-19 on Global Supply Chains: Facts and Perspectives
Xu, Z., Elomri, A., Kerbache, L., & El Omri, A. (2020) · IEEE Engineering Management Review · doi:10.1109/emr.2020.3018420 · Cited by 396
Innovation as recovery strategy for SMEs in emerging economies during the COVID-19 pandemic
Caballero-Morales, S.-O. (2021) · Research in International Business and Finance · doi:10.1016/j.ribaf.2021.101396 · Cited by 352
Observed and Potential Impacts of the COVID-19 Pandemic on the Environment
Cheval, S., Mihai Adamescu, C., Georgiadis, T., Herrnegger, M., Piticar, A., & Legates, D. R. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17114140 · Cited by 321
Gao, D., Xiang, Q., Lu, G., Tong, J., Jiang, W., Yu, X., Wang, R., Lv, Z., & Li, D. (2022) · BMC Psychology · doi:10.1186/s40359-022-00934-1 · Cited by 17
Extended producer responsibility practices and prospects for waste management in Japan
Ramasubramanian, B., Reddy, V. S., Paul, P., Dalapati, G. K., & Ramakrishna, S. (2024) · Sustainable Chemistry One World · doi:10.1016/j.scowo.2024.100009 · Cited by 15
Metadata
- Authors
- Ali, I., & Alharbi, O. M. L.
- Venue
- Science of The Total Environment
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 728
- Pages
- 138861
- ISSN
- 0048-9697 (ISSN-L)
- OpenAlex
- W3020052149
- Cited by
- 551
- References
- 38
- FWCI
- 14.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.